Pharmacy Continence Care - Bladder and Bowel Website

Executive Summary
The Pharmacy Continence Care Project was commissioned by the Pharmacy Guild of
Australia, through the Community Pharmacy Research and Development Grants Program, to
develop, trial and evaluate a pilot program for national implementation and inclusion in the
Quality Care Pharmacy Practice (QCPP) program that will:
• provide community pharmacists and assistants with the information and skills to
significantly raise community awareness of the issue of incontinence and to recognise
and promote help-seeking strategies by their customers
• promote widespread awareness of diagnosis and treatment services available
• encourage individuals to seek readily accessible, appropriate and discreet information
about their condition/symptoms.
A first stage of the project, undertaken in 2003 by the Western Australia Continence Advisory
Service, developed an education and training module for implementation in community
pharmacies. The second stage was commissioned in October 2004 to develop, implement
and evaluate a training program and materials for national roll-out in a subsequent stage of
the project.
NOVA Public Policy, a consortium of consultants in health, economic and social policy,
undertook the second stage of the project, from October 2004 to November 2005, and this
report presents the approach, methods, findings and outcomes of this stage.
The NOVA approach to the pilot Program comprised six elements, running contiguously and
sequentially through the life of the project.
In the inception phase, the NOVA project team consulted with the Pharmacy Guild of
Australia research staff to establish the project plan and timetable and a strategy to recruit
community pharmacies across Australia to participate in the project. NOVA also met with an
expert panel of clinicians, pharmacists and a carer, put together by NOVA to advise on the
development and implementation of the project.
The desk research element of the project proceeded in parallel with element 3,
Implementation of the Pilot Program, which comprised the recruitment of the research
sample of participating pharmacies, and consultation with stakeholders on pharmacy,
consumer issues and continence care information relevant to the project.
The Stage 1 training materials and a substantial range of other continence education and
training materials, developed through the National Continence Management Strategy or
identified through the literature review, were assessed and extensive adaptation of materials
was undertaken with clinical, academic and consumer advice and guidance from members of
the NOVA Expert Panel. The penultimate draft of the training materials was further reviewed
by the medical and pharmacy professionals on the Expert Panel and by the Pharmacy Guild
training manager, prior to submission to the Pharmacy Guild Expert Advisory Group in
February 2005.
The evaluation strategy for the project used a semi-structured two-stage telephone survey of
the participating pharmacies—at baseline and following conclusion of the pilot Program—to
measure change against Program objectives and performance indicators; and evaluation of
consumer benefits through recruitment of customers (people with or at risk of incontinence,
and carers) to a self-report survey instrument at enrolment (in-pharmacy) and by follow-up
telephone interview at three months post baseline. Evaluation of sustainability of the
Final Report ix NOVA Public Policy
Pharmacy Continence Care Project